Antidiabetic treatment trends in a cohort of elderly people with diabetes: The Cardiovascular Health Study, 1989-1997

Diabetes Care

Volumn 22, Issue 5, 1999, Pages 736-742

  Smith, Nicholas L ^a,f   Heckbert, Susan R ^a   Bittner, Vera A ^c   Savage, Peter J ^e   Barzilay, Joshua I ^b   Dobs, Adrian S ^d   Psaty, Bruce M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; BIGUANIDE; GLUCOSE; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; TROGLITAZONE;

AGED; ARTICLE; DRUG EFFICACY; DRUG INDICATION; FEMALE; FOLLOW UP; GERIATRIC CARE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS; DRUG THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 0032954650     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.5.736     Document Type: Article

References (27)

1. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 21 (Suppl. 1): S23-S31, 1998
2. American Diabetes Association: Consensus statement: the pharmacological treatment of hyperglycemia in NIDDM. Diabetes Care 18:1510-1518, 1995
3. Dagogo-Jack S, Santiago JV: Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Arch Intern Med 157:1802-1817, 1997
4. Bressler R, Johnson DG: Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus. Arch Intern Med 157:836-848, 1997
5. Gaster B, Hirsch IB: The effects of improved glycemic control on complications in type 2 diabetes. Arch Intern Med 158:134-140, 1998
6. Birkeland KI, Rishaug U, Hanssen KF, Vaaler S: NIDDM: a rapid progressive disease: results from a long-term, randomized, comparative study of insulin and sulfonylurea treatment. Diabetologia 39:1629-1633, 1996
7. Johnson JL, Wolf SL, Udaya MK: Efficacy of insulin and sulfonylurea combination therapy in type 11 diabetes. Arch Intern Med 156:259-264, 1996
8. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 11 Diabetes (VA CSDM): results of the feasibility trial, Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care 18:1113-1123, 1995
9. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995
10. United Kingdom Prospective Diabetes Study Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 33). Lancet 352:837-853, 1998
11. United Kingdom Prospective Diabetes Study Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
12. National Center for Health Statistics: Current estimates from the National Health Interview Survey, 1993. Vital and Health Statistics. 1994
13. Harris MI, Hadden WC, Knowler WC, Bennett PH: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years. Diabetes 36:523-534, 1987
14. Trends in the prevalence and incidence of self-reported diabetes mellitus: United States, 1980-1994. MMWR 46:1014-1018, 1997
15. Stolk RP, Pols HAP, Lamberts SWJ, de Jong PTVM, Hofman A, Grobbee DE: Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. The Rotterdam Study. Epidemiol 145:24-32, 1997
16. Blanchard FJ, Ludwig S, Wajda A, Dean H, Anderson K, Kendall O, Depew N: Incidence and prevalence of diabetes in Manitoba. Diabetes Care 19:807-811, 1996
17. Schwartz S, Raskin P, Fonseca V, Graveline JF: The Troglitazone and Exogenous Insulin Study Group: effect of troglitazone in insulin-treated patients with type II diabetes mellitus. N Engl J Med 338:861-866, 1998
18. Inzucchi SEM, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI: Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338: 867-872, 1998
19. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty BM, Rautaharju P, Tracy RP, Weiler PG: The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1:263-276, 1991
20. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP: Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41/2:264-270, 1995
21. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M: Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. J Clin Epidemiol 45:683-692, 1992
22. Landry JA, Smyer MA, Tubman JG, Lago DJ, Roberts J, Simonson W: Validation of two methods of data collection of self-reported medicine use among the elderly. Gerontologist 28:672-676, 1988.
23. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
24. WHO Expert Committee on Diabetes Mellitus: Second Report Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
25. Altman DG: Practical Statistics for Medical Research. London, Chapman and Hall, p. 235-241, 1991
26. Efron B, Tibshirani R: Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1:54-77, 1986
27. Logistic Regression Procedure. SAS Version 6.12. SAS Institute, Inc., Cary, NC